Should You Buy Banco Santander SA (SAN) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Buy
Latest Price
12.680
1 Day change
-2.84%
52 Week Range
13.050
Analysis Updated At
2026/01/26
Banco Santander SA (SAN) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows positive financial growth, hedge fund buying interest, and bullish moving averages, despite minor negative news. The absence of significant AI Stock Picker or SwingMax signals does not detract from its long-term potential.
Technical Analysis
The stock is showing bullish moving averages (SMA_5 > SMA_20 > SMA_200), indicating an upward trend. RSI is neutral at 65.868, and MACD is slightly negative but contracting. Key resistance is at 12.569, with current pre-market price at 12.53, close to breaking resistance levels.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Technical Summary
Sell
3
Buy
9
Positive Catalysts
Hedge funds are heavily buying, with a significant increase of 87575.41% over the last quarter.
Financial performance shows strong YoY growth in revenue (+0.67%), net income (+14.70%), and EPS (+21.74%).
Recent fine of €40 million by Spain's SEPBLAC for deficiencies in internal processes at Openbank.
No significant insider trading trends.
Analysts' ratings are mixed, with some downgrades and neutral stances.
Financial Performance
In Q3 2025, Banco Santander reported a revenue increase of 0.67% YoY to $16.64 billion, net income growth of 14.70% YoY to $4.10 billion, and EPS growth of 21.74% YoY to $0.28. These figures indicate strong financial health and growth.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Analysts' ratings are mixed. Recent downgrades include DZ Bank lowering to Hold with a EUR 10 price target. However, Morgan Stanley and Citi maintain Buy or Overweight ratings with price targets between EUR 10 and EUR 11.
Wall Street analysts forecast SAN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SAN is 7.4 USD with a low forecast of 4.9 USD and a high forecast of 9.91 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast SAN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SAN is 7.4 USD with a low forecast of 4.9 USD and a high forecast of 9.91 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
1 Hold
1 Sell
Moderate Sell
Current: 13.050
Low
4.9
Averages
7.4
High
9.91
Current: 13.050
Low
4.9
Averages
7.4
High
9.91
JPMorgan
Neutral
maintain
$30 -> $38
AI Analysis
2026-01-16
Reason
JPMorgan
Price Target
$30 -> $38
AI Analysis
2026-01-16
maintain
Neutral
Reason
JPMorgan raised the firm's price target on Santander Chile to $38 from $30 and keeps a Neutral rating on the shares. The firm adjusted Chilean bank targets as part of a Q4 preview. It sees a "mixed quarter" for the sector amid lower inflation, but says investors will likely ignore that and focus on 2026 guidance and trends for 2027.
Barclays
Overweight -> Equal Weight
downgrade
€85
2026-01-06
Reason
Barclays
Price Target
€85
2026-01-06
downgrade
Overweight -> Equal Weight
Reason
As previously reported, Barclays downgraded Sanofi to Equal Weight from Overweight with an EUR 85 price target as the firm transferred coverage of European large-cap pharma to a new analyst. The downgrade balances a low valuation and "strong" operational outlook with the lack of late stage pipeline opportunities and the approaching Dupixent loss of exclusivity, the analyst tells investors.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for SAN
